By Colin Kellaher
Shares of iCAD took flight in premarket trading Wednesday after the medical-technology company agreed to be acquired by diagnostic-imaging-services provider RadNet in a stock swap valued at about $103 million.
RadNet on Tuesday said it will issue 0.0677 shares, worth about $3.59 based on Tuesday's closing price of $53.08 for the Los Angeles company, for each share of iCAD.
The deal, slated to close in the second or third quarter, represents a roughly 86% premium to Tuesday's closing price of $1.93 for iCAD, based in Nashua, N.H.
ICAD shares were recently up 73% at $3.34 in premarket trading.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 16, 2025 06:14 ET (10:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。